U.S. Judge Lourdes G. Baird of the Central District of California has entered a permanent injunction ordering Pfizer Inc. to cease using the mark Trovan to identify an antibiotic (Trovan Ltd., et al. v. Pfizer Inc., No. CV-98-0094 LGB, C.D. Calif.).
The judge’s Feb. 24 order also finalized an Oct. 12 jury award of $143 million for Trovan Ltd., a British company which owns the registered trademark Trovan, and its American licensee, Electronic Identification Devices Ltd. She denied the plaintiffs’ motion for treble damages or profits, finding the $143 million jury award ample compensation. The award, believed to be the largest trademark infringement verdict ever entered, consists of $5 million in general damages, $3 million in royalties and $135 million in punitive damages.
